성장을 멈추지 마세요

체험은 만족하셨나요?

현재 45,775명이 마이메르시로 공부 중이에요

지식 자료를 소장하고 멋진 의료인으로 성장하세요

학습 자료 둘러보기 →
Posttransplantation Immunodeficiency | 마이메르시 MyMerci
제안하기

뭔가 하고 싶은 말이 있는거야?

0 / 2000
컨텐츠 수정하기

컨텐츠 내용을 수정할 수 있습니다

수정하기
닫기

Posttransplantation Immunodeficiency

NCLEX Review Guide: Posttransplantation Immunodeficiency

Immunosuppressive Therapy Overview

Primary Immunosuppressive Medications

  • Calcineurin inhibitors (Tacrolimus, Cyclosporine) prevent T-cell activation and are considered first-line therapy for most organ transplants
  • Antimetabolites (Mycophenolate, Azathioprine) block DNA synthesis in rapidly dividing immune cells, reducing rejection risk
  • Corticosteroids (Prednisone) provide broad anti-inflammatory effects but require careful tapering to prevent withdrawal symptoms
  • mTOR inhibitors (Sirolimus) block cell cycle progression and are often used when nephrotoxicity is a concern

Memory Aid: "CATS" for Immunosuppression

Calcineurin inhibitors, Antimetabolites, Tacrolimus (most common), Steroids

Key Points

  • Triple therapy (calcineurin inhibitor + antimetabolite + steroid) is standard protocol
  • Medication levels require frequent monitoring, especially tacrolimus and cyclosporine
  • Never abruptly discontinue immunosuppressive medications

Infection Prevention and Management

High-Risk Infections

  • Opportunistic infections are the leading cause of morbidity and mortality in transplant recipients during the first year
  • Cytomegalovirus (CMV) is the most common viral infection, requiring prophylactic antiviral therapy in high-risk patients
  • Pneumocystis jirovecii pneumonia (PCP) requires trimethoprim-sulfamethoxazole prophylaxis for 6-12 months post-transplant
  • Bacterial infections often present with atypical symptoms due to blunted inflammatory response

Clinical Scenario

A 45-year-old kidney transplant recipient (3 months post-transplant) presents with low-grade fever and dry cough. Despite minimal symptoms, immediate evaluation is critical as immunosuppression masks typical infection presentations.

    Infection Assessment Protocol

  1. Obtain comprehensive history including recent exposures and travel
  2. Perform thorough physical examination, noting subtle changes
  3. Order complete blood count, comprehensive metabolic panel, and cultures
  4. Consider chest imaging even with minimal respiratory symptoms
  5. Initiate empirical therapy if serious infection suspected

Malignancy Surveillance

Increased Cancer Risk

  • Skin cancers occur 20-100 times more frequently in transplant recipients, requiring annual dermatologic screening
  • Post-transplant lymphoproliferative disorder (PTLD) is often EBV-related and may require reduction in immunosuppression
  • Kaposi's sarcoma and other viral-associated malignancies have increased incidence
  • Renal cell carcinoma risk is particularly elevated in kidney transplant recipients

Key Points

  • Sun protection education is essential - daily sunscreen, protective clothing
  • Age-appropriate cancer screening should be accelerated and more frequent
  • Any new mass or lesion requires immediate evaluation

Commonly Confused Concepts

Rejection vs. Infection vs. Drug Toxicity

ConditionOnsetKey FeaturesLaboratory Findings
Acute RejectionDays to weeksOrgan dysfunction, fever possibleElevated organ-specific markers
InfectionVariableFever, malaise, atypical presentationElevated WBC (may be normal)
Drug ToxicityDose-relatedOrgan-specific symptomsElevated drug levels

Memory Aid: "RED FLAGS" for Complications

Rejection signs, Elevated creatinine, Decreased urine output, Fever, Low WBC, Atypical infections, GI symptoms, Skin changes

Study Tips and Quick Checks

Priority Nursing Interventions

  • Hand hygiene is the most important infection prevention measure for immunocompromised patients
  • Medication adherence education prevents rejection episodes and maintains therapeutic drug levels
  • Vital sign monitoring must include temperature assessment at every encounter
  • Patient education about infection prevention, medication compliance, and when to seek medical attention

Common Pitfalls to Avoid

  • Don't assume normal WBC count rules out infection in immunocompromised patients
  • Never delay antibiotic therapy while waiting for culture results in symptomatic patients
  • Don't forget to assess for drug interactions with immunosuppressive medications

Quick Check Questions

☐ Can you name the three main classes of immunosuppressive drugs?

☐ What is the most common opportunistic infection in transplant recipients?

☐ Why is skin cancer screening so important post-transplant?

☐ What are the key differences between rejection and infection presentation?

Remember: You're preparing to save lives and provide exceptional patient care. Every concept you master brings you closer to becoming the nurse your patients need. Stay focused, stay motivated, and trust in your preparation!

다음 이론을 계속 학습하려면 로그인하세요.

로그인하고 계속 학습
컨텐츠를 그만볼래?

필기노트, 하이라이터, 메모는 잘 쓰고 있어?

내보내줘
어떤 폴더에 저장할래?

컨텐츠 노트에는 총 0개의 폴더가 있어!

폴더 만들기
컨텐츠 만들기
만들기
신고했어요.

운영진이 검토할게요!

해당 유저를 차단했어요.

마이페이지에서 차단한 회원을 관리할 수 있어요.